MedPath

苏州吴淞江制药有限公司

Ownership
-
Established
2014-04-04
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

3

NMPA:3

Drug Approvals

芩苓子阴道灌注液

Product Name
严馨
Approval Number
国药准字Z20194010
Approval Date
Aug 9, 2023
NMPA

Montelukast Sodium Oral Granules

Product Name
孟鲁司特钠颗粒
Approval Number
国药准字H20203429
Approval Date
Aug 17, 2020
NMPA

Clindamycin Phosphate Vaginal Effervescent Tablets

Product Name
克林霉素磷酸酯阴道泡腾片
Approval Number
国药准字H20153018
Approval Date
Dec 27, 2019
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.